Researchers from the University of Illinois at Chicago have identified a protein that is crucial for activating inflammation—both the good kind of inflammation that leads to healing wounds and fighting infection, as well ...
Jun 27, 2018
0
390
University of Wisconsin-Madison scientists have discovered that a majority of back-pain patients they tested who were taking opioid painkillers produced anti-opioid antibodies.
Aug 17, 2020
0
399
For many COVID-19 patients battling for their lives in the ICU, a runaway immune system response—known as a "cytokine storm"—is their primary foe.
Apr 28, 2020
0
594
"How many people actually have this disease?"
Feb 28, 2022
0
71
Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, ...
Apr 25, 2011
0
1
Peter Mac clinicians have described how a young patient with a rare, aggressive and only recently described form of acute myeloid leukemia (AML) has responded to genomically-guided targeted therapy.
Jun 27, 2024
0
9
It's a scary struggle. Forget guns, bullets, bombs and drones. Humans are entangled in a far more lethal world war than the conflicts often described in the news. The numbers and potential kill factors are frightening. Ebola ...
Jun 29, 2015
1
103
The mRNA vaccines for COVID-19, made by Pfizer/BioNTech and Moderna, are among the most powerful vaccines the world has ever seen. According to clinical trial data, they are more than 94% effective at preventing symptomatic ...
Jul 14, 2021
1
582
A new approach to cancer therapy shows potential to transform the commonly used chemotherapy drug gemcitabine into a drug that kills cancer cells in a specialized way, activating immune cells to fight the cancer, according ...
Dec 7, 2020
0
339
While the focus has been largely on vaccines, you might have also heard Pfizer is trialing a pill to treat COVID-19.
Jun 1, 2021
0
4
